


Pericarditis and Autoinflammation: A Clinical and Genetic Analysis of Patients With Idiopathic Recurrent Pericarditis

Cardiol Therapeutics Announces FDA Investigational New Drug Application…

Kiniksa Announces FDA Approval of Arcalyst

THE AUTOINFLAMMATORY SIDE OF RECURRENT PERICARDITIS: ENLIGHTENING THE PATHOGENESIS FOR A MORE RATIONAL TREATMENT
